Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H39NO3 |
Molecular Weight | 317.5072 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO
InChI
InChIKey=AERBNCYCJBRYDG-KSZLIROESA-N
InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1
Phytosphingosine is structural analog of sphingolipids and is classified as long-chain sphingoid base. Phytosphingosine significantly induced chromatin DNA fragmentation. Phytosphingosine caused strong induction of caspase-8 activity and caspase-independent Bax translocation to the mitochondria. It shows excellent clinical results in the context of skin care in acne, based on both anti-inflammatory and anti-microbial activity. Phytosphingosine is currently seen in a variety of products as a skin and hair conditioning agent. Phytosphingosine might serve as an effective melanogenesis inhibitor in melanocytes via the regulation of the MITF signaling pathways. Dietary supplementation of phytosphingosine decreases plasma cholesterol levels and enhances insulin sensitivity in men with the metabolic syndrome.
Originator
Sources: DOI: 10.1007/BF01519846
Curator's Comment: Cerebrin base was iirst isolated from mushrooms by Zellner and later from yeast by Reindel. Carter et al. isolated a long-chain base from corn phosphatide and showed it to be identical to cerebrin base. Its structure was established as 1,3,4-trihydroxy-2-aminooctadecane and it was named phytosphingosine. https://www.ncbi.nlm.nih.gov/pubmed/14018956
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: MITF signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/28390782 |
|||
Target ID: map04210 |
|||
Target ID: GO:0006309 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15723652 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Inactive ingredient | CheryLee MD TrueLipids Relieve and Protect Ointment Approved UseUses:
helps relieve, prevent and temporarily protect chafed, chapped, cracked or windburned skin and lips
temporarily protects minor:
cuts
scrapes
burns
helps protect from the drying effects of wind and cold weather |
PubMed
Title | Date | PubMed |
---|---|---|
Functional characterization of sphingolipid C4-hydroxylase genes from Arabidopsis thaliana. | 2001 Apr 6 |
|
C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. | 2001 Jun 1 |
|
Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae. | 2001 Mar 16 |
|
Dependence of the sphingoid bases concentration on growth phase and temperature in the yeast Yarrowia lipolytica. | 2002 |
|
Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. | 2002 Apr 15 |
|
Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. | 2002 Aug |
|
[Experimental survey of a new topical anti-oxidant based on furfuryl palmitate in the treatment of child's and baby's dermatitis with eczema: results from a multicenter clinical investigation]. | 2002 Oct |
|
Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. | 2003 Dec 12 |
|
Induction of apoptosis and expression of cell cycle regulatory proteins in response to a phytosphingosine derivative in HaCaT human keratinocyte cells. | 2003 Dec 31 |
|
Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry. | 2003 Jul |
|
Synthesis of 4-hydroxysphinganine and characterization of sphinganine hydroxylase activity in corn. | 2003 Jul 15 |
|
The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. | 2003 May 1 |
|
Tetraacetyl phytosphingosine-induced caspase activation and apoptosis occur through G2 arrest in human keratinocyte HaCaT cells. | 2003 Nov |
|
Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. | 2003 Nov |
|
Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. | 2003 Oct 15 |
|
Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. | 2003 Sep 12 |
|
Carbohydrate recognition by enterohemorrhagic Escherichia coli: characterization of a novel glycosphingolipid from cat small intestine. | 2004 Feb |
|
Structure and biological functions of fungal cerebrosides. | 2004 Mar |
|
Anti-ulcer actions of phytosphingosine hydrochloride in different experimental rat ulcer models. | 2005 |
|
A novel coaxial electrospray ionization method for characterizing hexacosanoylceramides by Fourier transform ion cyclotron resonance mass spectrometry. | 2005 |
|
Lipid mixtures prepared with well-defined synthetic ceramides closely mimic the unique stratum corneum lipid phase behavior. | 2005 Dec |
|
Phosphorylation of sphingoid long-chain bases in Arabidopsis: functional characterization and expression of the first sphingoid long-chain base Kinase gene in plants. | 2005 Feb |
|
Arabidopsis sphingosine kinase and the effects of phytosphingosine-1-phosphate on stomatal aperture. | 2005 Feb |
|
Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. | 2005 Feb 15 |
|
The sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9. | 2005 Jun 17 |
|
FTIR spectroscopic studies of lipid dynamics in phytosphingosine ceramide models of the stratum corneum lipid matrix. | 2005 Mar |
|
Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. | 2005 May |
|
Inositol phosphoceramide synthase is a regulator of intracellular levels of diacylglycerol and ceramide during the G1 to S transition in Saccharomyces cerevisiae. | 2005 May 15 |
|
Candida albicans serotype B strains synthesize a serotype-specific phospholipomannan overexpressing a beta-1,2-linked mannotriose. | 2005 Nov |
|
Regulation of the sphingoid long-chain base kinase Lcb4p by ergosterol and heme: studies in phytosphingosine-resistant mutants. | 2005 Nov 4 |
|
APP1 transcription is regulated by inositol-phosphorylceramide synthase 1-diacylglycerol pathway and is controlled by ATF2 transcription factor in Cryptococcus neoformans. | 2005 Oct 28 |
|
Structure-activity relationships of dimethylsphingosine (DMS) derivatives and their effects on intracellular pH and Ca2+ in the U937 monocyte cell line. | 2006 Aug |
|
Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. | 2006 Dec |
|
Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema--an in vivo study. | 2006 Jan 13 |
|
Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. | 2006 Jan-Mar |
|
An efficient high-yield synthesis of D-ribo-phytosphingosine. | 2006 Jul 20 |
|
A general, efficient and stereospecific route to sphingosine, sphinganines, phytosphingosines and their analogs. | 2006 Mar 21 |
|
Efficient synthesis of D-erythro-sphingosine and D-erythro-azidosphingosine from D-ribo-phytosphingosine via a cyclic sulfate intermediate. | 2006 Oct 27 |
|
Constituents of Holothuroidea, 18. Isolation and structure of biologically active disialo- and trisialo-gangliosides from the sea cucumber Cucumaria echinata. | 2006 Sep |
|
Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells. | 2007 Jan |
|
Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. | 2007 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20179727
500 mg twice daily for a 4 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14522966
Jurkat and NCI-H460 cells were treated with 5 or 10 ug/ml phytosphingosine, respectively, for the 2, 5, 10, 30, 60, 120 min. phytosphingosine treatment
led to a dramatic down-regulation of phosphorylated ERK1/2. The phosphorylated ERK started to diminish within 2 min of the phytosphingosine treatment.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14119
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
Phytosphingosine
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
46961
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
122121
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
100000128321
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
DTXSID80203951
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
1363444
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | RxNorm | ||
|
GIN46U9Q2Q
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
554-62-1
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
SUB35223
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY | |||
|
GIN46U9Q2Q
Created by
admin on Fri Dec 15 20:03:47 GMT 2023 , Edited by admin on Fri Dec 15 20:03:47 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)